Dr. Christy shares her excitement about Zepbound - going over the data and the reasons why this is moving obesity medicine forward.
REFERENCES:
https://investor.lilly.com/news-relea...
SURMOUNT-1 data: https://www.nejm.org/doi/full/10.1056...
SURMOUNT-2 data: https://www.thelancet.com/journals/la...